Ebola Vaccine Generates Antibody Response, Study Finds

Reuters (9/13, Kalia) reports Johnson & Johnson “said on Monday its Ebola vaccine regimen demonstrated antibody immune responses in adults and children, citing data published in The Lancet Infectious Diseases journal.” The company’s “two-dose regimen was...